Novartis Global Service Center, Dublin, Ireland.
Novartis Pharma AG, Basel, Switzerland.
J Neuromuscul Dis. 2017;4(2):127-137. doi: 10.3233/JND-160198.
Sporadic Inclusion Body Myositis (sIBM) is a rare and slowly progressive debilitating muscle disease with symptoms generally developing≥50 years of age.
To conduct a systematic review and meta-analysis of the prevalence of sIBM literature, including a methodological quality assessment of the selected papers.
A systematic search of Medline, Embase, Cochrane Database of Systematic Reviews and major Myositis and Neurological conferences was conducted. Articles reporting prevalence and published in English up to March 2017 were assessed for methodology quality using the Loney quality assessment, Downs & Black score, and the Methodological Evaluation of Observational Research checklists. Meta-analyses using random effects were completed on both general population and≥50 years prevalence estimates.
315 articles were retrieved and data were extracted from 10 relevant studies. One study was subsequently excluded due to methodological issues. The meta-prevalence estimate from 9 papers was 24.8/1,000,000 (95% CI: 20.0-29.6). The methodological quality results were consistent across assessment tools with four articles scoring 4 or 5 out of 8 in the Loney assessment. The meta-prevalence of these four articles was 45.6/ 1,000,000 (95% CI: 35.9-55.2).
There was high variability in reported sIBM prevalence estimates and the quality of the studies conducted. Existing evidence suggests an increase of prevalence estimates over time, which may be explained by growing disease awareness, improvements in diagnostic criteria and study methodologies. Further high quality studies are needed to understand if prevalence varies across geographies or ethnicities.
散发性包涵体肌炎(sIBM)是一种罕见的、进行性缓慢的使人虚弱的肌肉疾病,其症状通常在≥50 岁时出现。
对 sIBM 文献的患病率进行系统回顾和荟萃分析,包括对所选论文进行方法学质量评估。
对 Medline、Embase、Cochrane 系统评价数据库和主要肌炎和神经病学会议进行系统检索。评估报告患病率并以英文发表的文章,直到 2017 年 3 月,使用 Loney 质量评估、Downs 和 Black 评分以及观察性研究方法评估清单进行方法学质量评估。使用随机效应进行荟萃分析,分析一般人群和≥50 岁人群的患病率估计值。
检索到 315 篇文章,从 10 项相关研究中提取数据。由于方法学问题,有一项研究随后被排除在外。9 篇论文的荟萃患病率估计值为 24.8/100 万(95%CI:20.0-29.6)。评估工具的方法学质量结果一致,四项研究在 Loney 评估中得分为 4 或 5 分(满分 8 分)。这四项研究的荟萃患病率为 45.6/100 万(95%CI:35.9-55.2)。
报告的 sIBM 患病率估计值和研究质量存在很大差异。现有证据表明,患病率随时间推移而增加,这可能是由于疾病意识的提高、诊断标准和研究方法的改进所致。需要进一步开展高质量的研究,以了解患病率是否因地理位置或种族而异。